"10.1371_journal.pone.0010030","plos one","2010-04-06T00:00:00Z","Olga Gil; Ivan Díaz; Cristina Vilaplana; Gustavo Tapia; Jorge Díaz; María Fort; Neus Cáceres; Sergio Pinto; Joan Caylà; Leigh Corner; Mariano Domingo; Pere-Joan Cardona","Unitat de Tuberculosi Experimental (UTE), Institut per a la Investigació en Ciències de la Salut Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain; CIBER Enfermedades Respiratorias, Instituto Carlos III, Palma de Mallorca, Spain; Centre de Recerca en Sanitat Animal (CReSA) (UAB-IRTA), Bellaterra, Catalonia, Spain; Pathology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain; Tuberculosis Investigation Unit of Barcelona, Servei dEpidemiologia, Agència de Salut Pública, Barcelona, Catalonia, Spain; School of Agriculture, Food Science and Veterinary Medicine, University College Dublin, Dublin, Ireland","Conceived and designed the experiments: OG ID CV LC MD PJC. Performed the experiments: OG ID CV GT JD MF NC SP LC MD PJC. Analyzed the data: OG ID CV GT NC JC LC MD PJC. Contributed reagents/materials/analysis tools: ID GT JD MF SP JC MD PJC. Wrote the paper: OG ID CV NC PJC. All authors listed contributed to conception and design, or acquisition of data or analysis and interpretation of data; to drafting the article or revising it critically for important intellectual content; and gave the final approval of the version to be published.","PJC is co-inventor of the patent claiming RUTI® as a therapeutic vaccine. Regulatory approval and further clinical development is currently being undertaken by a spin-off, the biopharmaceutical company Archivel Farma S.L., in collaboration with the Institut Germans Trias i Pujol. PJC is the Scientific Director of this spin-off. The authors confirm that this does not alter their adherence to all the PLoS ONE policies on sharing data and materials.","2010","04","Olga Gil","OG",12,TRUE,6,11,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
